In this AD model, the loss of Sma-9, a transcriptional cofactor of the TGF-β pathway, increases Aβ deposits. As Sma-9 also plays a role in ROS production and neuroprotection, it is a potential drug target for the prevention of AD neurodegeneration [171]. More generally, TGF-β, ...